In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer

Clinical trial NCT01923233 · WITHDRAWN

Trial details

NCT number: NCT01923233
Sponsor: Mirror Biologics, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-11-01
Primary completion: 2015-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.